KM Financial Solutions | UPDATE 1-Investor group presses U.S. drug companies on opioid controls
2614
post-template-default,single,single-post,postid-2614,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Investor group presses U.S. drug companies on opioid controls

UPDATE 1-Investor group presses U.S. drug companies on opioid controls

BOSTON, Oct 30 (Reuters) – U.S. shareholder activists are
addressing a soaring death toll from opioid drug abuse, asking
companies that make and distribute the painkillers to review the
risks their businesses could face from their role in the sector.

No Comments

Post A Comment